Cannabis Impacts Tumor Response Rate to Nivolumab in Patients With Advanced Malignancies

Oncologist - United States
doi 10.1634/theoncologist.2018-0383
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Effect of Trabectedin on the QT Interval in Patients With Advanced Solid Tumor Malignancies

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2011English

A Phase 1 Study of Cetuximab and Lapatinib in Patients With Advanced Solid Tumor Malignancies

Cancer
Cancer ResearchOncology
2015English

Nivolumab Improves Survival for Patients With Advanced Lung Cancer

Cancer
Cancer ResearchOncology
2017English

182P: Intracranial Response to Nivolumab in NSCLC Patients With Untreated or Progressing CNS Metastases

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Evaluating the Safety and Efficacy of Nivolumab in Patients With Advanced Hepatocellular Carcinoma: Evidence to Date

OncoTargets and Therapy
OncologyPharmacology
2019English

A Phase I Study of Indoximod in Patients With Advanced Malignancies

Oncotarget
Oncology
2016English

Predictors of Survival in Patients With Advanced Gastrointestinal Malignancies Admitted to the Intensive Care Unit

Oncologist
Cancer ResearchMedicineOncology
2018English

Circulating Tumor DNA Evaluated by Next-Generation Sequencing Is Predictive of Tumor Response and Prolonged Clinical Benefit With Nivolumab in Advanced Non-Small Cell Lung Cancer

OncoImmunology
OncologyAllergyImmunology
2018English

Outcome of Vulvar Reconstruction in Patients With Advanced and Recurrent Vulvar Malignancies

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy